Scientific and Medical Equipment House Company (4014.SR)
SAR 41.3
(0.12%)
SAR 41.3
(0.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 597.27 Million SAR | 29.17% |
| 2022 | 462.4 Million SAR | -15.02% |
| 2021 | 544.14 Million SAR | -38.82% |
| 2020 | 889.38 Million SAR | 3.2% |
| 2019 | 861.81 Million SAR | 1.96% |
| 2018 | 845.27 Million SAR | 28.61% |
| 2017 | 657.25 Million SAR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 511.24 Million SAR | -12.51% |
| 2024 Q1 | 584.3 Million SAR | -2.17% |
| 2023 Q4 | 597.27 Million SAR | -3.0% |
| 2023 FY | 597.27 Million SAR | 29.17% |
| 2023 Q3 | 615.74 Million SAR | 5.29% |
| 2023 Q2 | 584.8 Million SAR | 12.21% |
| 2023 Q1 | 521.18 Million SAR | 12.71% |
| 2022 Q3 | 573.13 Million SAR | -11.38% |
| 2022 Q2 | 646.73 Million SAR | 10.53% |
| 2022 FY | 462.4 Million SAR | -15.02% |
| 2022 Q1 | 585.14 Million SAR | 7.53% |
| 2022 Q4 | 462.4 Million SAR | -19.32% |
| 2021 Q2 | 569.35 Million SAR | 0.0% |
| 2021 Q1 | - SAR | -100.0% |
| 2021 FY | 544.14 Million SAR | -38.82% |
| 2021 Q4 | 544.14 Million SAR | 0.0% |
| 2020 FY | 889.38 Million SAR | 3.2% |
| 2020 Q1 | - SAR | 0.0% |
| 2020 Q4 | 459.43 Million SAR | 0.0% |
| 2020 Q3 | 459.43 Million SAR | 0.0% |
| 2019 FY | 861.81 Million SAR | 1.96% |
| 2018 FY | 845.27 Million SAR | 28.61% |
| 2017 FY | 657.25 Million SAR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|